This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) rose 1.14% to $292.88 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.79% to 6,774.76 and the Dow Jones Industrial Average  rising 0.14% to 47,951.85.
This was the stock's second consecutive day of gains.
Insulet Corp. closed 17.47% below its 52-week high of $354.88, which the company reached on November 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Eli Lilly &amp; Co. (LLY) rose 1.45% to $1,056.88, DexCom Inc. (DXCM) rose 0.24% to $65.91, and Johnson &amp; Johnson (JNJ) fell 0.96% to $208.31.
Trading volume (748,199) eclipsed its 50-day average volume of 658,783.
Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-18-25 1707ET

PODD

<p>Insulet Corp.'s stock rose 1.14% to $292.88 on Thursday, underperforming compared to competitors like Eli Lilly & Co. and DexCom Inc. despite daily gains. The stock remains 17.47% below its 52-week high. Trading volume exceeded its 50-day average.</p>

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains